Discovery and Biological Evaluation of Proteolysis Targeting Chimeras (protacs) As an EGFR Degraders Based on Osimertinib and Lenalidomide.
Bioorganic & Medicinal Chemistry Letters（2020）
关键词
Proteolysis targeting chimera,CRBN,EGFR-TK degrader,Osimertinib,Lenalidomide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要